55.64
price down icon4.87%   -2.85
pre-market  Pre-mercato:  56.47   0.83   +1.49%
loading

Vaxcyte Inc Azioni (PCVX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
7.14%
242.38
226.22 180.79 162.17 139.92
Operating Income/Loss
7.14%
-242.38
-226.22 -180.79 -162.17 -139.92
Nonoperating Income/Loss
50.46%
29.55
59.65 40.08 - -
Income/Loss From Continuing Operations Before Tax
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Net Income/Loss
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.12%
136.20
136.03 135.69 4.4009 123.69
Diluted Average Shares
0.12%
136.20
136.03 135.69 4.4009 123.69
Basic Earnings Per Share
27.87%
-1.56
-1.22 -1.04 -1.02 -0.83
Diluted Earnings Per Share
27.87%
-1.56
-1.22 -1.04 -1.02 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):